A delegation of Hong Kong ArbeleBio China Chief Operating Officer and head of R&D visited Shenzhen C
Our chairman Professor Shi Yuanyuan, chief scientist Professor Wang Jianxun, chief consultant Dr.David Jin, Deputy General manager Tang Xiaomeng, Researching Department director Zhao Lijun and Marketing Department director Yang Jianglong warmly received.
Led by Wei Zheng, Assistant chairman of the Board, ArbeleBio experts visited the exhibition hall, production workshop and research and development laboratory, and had a preliminary understanding of the development history of Shenzhen Cell Valley, core technology patents, the role and advantages of retrovirus vectors in cell therapy, and highly appreciated the advanced technology and innovation strength of Shenzhen Cell Valley.
At the symposium, first of all, Professor Shi Yuanyuan warmly welcomed the arrival of ArbeleBio experts, and then they discussed the recent enterprise scientific research progress, cell therapy technology, viral vector application, market prospects, and project landing plans.Professor Shi Yuanyuan introduced in detail the core technology of Shenzhen Cell Valley, the unique manufacture process of retroviral vector (such as PackRV-SS system) and cell products such as CAR-T, CAR-NK and TCR-T, which can realize low-cost and high-quality industrial production for pharmaceutical companies.In addition, significant breakthroughs have been made in the culture expansion and transduction efficiency of CAR-NK, CAR-γδT, etc., providing new possibilities for the treatment of solid tumors.Teresa presented ArbeleBio's core proprietary technology platform focused on immunotherapy, and Arbele's unique bisspecific antibody innovations are currently IND filed in Hong Kong and Australia for the treatment of advanced gastrointestinal malignancies.
Teresa said that ArbeleBio has been committed to research and development in the field of biomedicine and hopes to carry out IIT clinical studies on solid tumors through cooperation with Shenzhen Cell Valley as soon as possible.Through this visit, they laid a solid foundation for ArbeleBio's follow-up in product research and development, marketing and other aspects.
Teresa said that ArbeleBio has been committed to research and development in the field of biomedicine and hopes to carry out IIT clinical studies on solid tumors through cooperation with Shenzhen Cell Valley as soon as possible.Through this visit, they laid a solid foundation for ArbeleBio's follow-up in product research and development, marketing and other aspects.
